 |
Sionna Therapeutics
Last updated: June 15, 2024
CEO Mike Cloonan
USA | Funding: $292M (+)
Website: https://www.sionnatx.com/
Sionna’s batch of small molecules will be the first to fully restore function to the cystic fibrosis transmembrane conductance regulator (CFTR) protein
Website: https://www.sionnatx.com/
Sionna’s batch of small molecules will be the first to fully restore function to the cystic fibrosis transmembrane conductance regulator (CFTR) protein
